Nova Pneuma Inc.
Clinical trials sponsored by Nova Pneuma Inc., explained in plain language.
-
New inhaler shows promise for quieting seizure triggers in Light-Sensitive epilepsy
Symptom relief CompletedThis study tested whether a single inhaled dose of Staccato Alprazolam can reduce seizure-related brain activity in people with photosensitive epilepsy. Five adults aged 18 to 60 with a history of light-triggered brain responses took part. Researchers measured changes in brain wa…
Phase: PHASE2 • Sponsor: Nova Pneuma Inc. • Aim: Symptom relief
Last updated May 26, 2026 06:19 UTC
-
Inhaled migraine med passes early safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a single inhaled dose of prochlorperazine (a drug used for migraines) in 54 healthy adults aged 18 to 45. The goal was to see if it was safe and tolerable, and to measure how the body absorbs and processes the drug. No treatment benefit was measured;…
Phase: PHASE1 • Sponsor: Nova Pneuma Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 06:25 UTC
-
Inhaled anxiety drug tested for abuse risk in sedative users
Knowledge-focused CompletedThis study looked at whether an inhaled form of the anxiety drug alprazolam is more or less likely to be abused than the standard pill. Thirty-one adults with a history of sedative abuse took part. Researchers measured how much participants wanted to take the drug again and how m…
Phase: PHASE1 • Sponsor: Nova Pneuma Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Heart safety study finds no major risks from inhaled drug
Knowledge-focused CompletedThis study looked at whether Staccato Loxapine, an inhaled drug, affects the heart's electrical activity in 48 healthy volunteers. Participants received the drug, a placebo, and another control in a crossover design. The goal was to measure changes in heart rhythm, not to treat a…
Phase: PHASE1 • Sponsor: Nova Pneuma Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC
-
Inhaled nausea drug passes early safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested an inhaled form of the anti-nausea drug granisetron in 36 healthy adults. The goal was to check its safety and how the body processes it, comparing different doses and an IV version. No treatment was given for any disease; the study simply gathered s…
Phase: PHASE1 • Sponsor: Nova Pneuma Inc. • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC